Childhood Immunisations (5 years and over)

Introduction

After clean water, vaccination is the most effective public health intervention in the world for saving lives and promoting good health. Immunisation is the most essential way of protecting people and communities from serious infectious diseases. As well as the individual being protected themselves, vaccinated people are also less likely to be a source of infection to others.

Many vaccine-preventable childhood diseases are now so rare that it is easy to underestimate the importance of children's vaccinations. However, whooping cough and diphtheria are still a threat. The diseases are rare now, but if children are not vaccinated, they can return with a vengeance.

Currently the European Region of the World Health Organization (WHO) recommends that on a national basis at least 95% of children are immunised against diseases preventable by immunisation and targeted for elimination or control (specifically, diphtheria, tetanus, pertussis, polio, Hib, measles, mumps and rubella).¹ The routine childhood immunisation programme for the UK includes these immunisations recommended by WHO as well as a number of others as defined by the UK Health Security Agency (UKHSA). The complete routine immunisation schedule is published annually by the UK Health Security Agency.

Childhood immunisations (0-4 years) and adult vaccinations provides data on younger children and adults. Further information on infectious diseases and other noncommunicable health threats is available in the Health Protection section.

Facts, figures and trends

In addition to vaccination data published by UKHSA, coverage data can be accessed via an experimental interactive dashboard: Childhood Vaccination Coverage Statistics for Local Authorities and Regions and from the Office for Health Improvement and Disparities (OHID) Child and Maternal Health profile.

Note: The COVID-19 period impacted vaccination and immunisations programmes in a number of ways. During the COVID-19 period, coverage for some vaccinations dropped across the country, for example in relation to measles, mumps and rubella (MMR) vaccination. The UK Heath Security Agency has warned that susceptibility will have increased in recent years, with the potential for larger outbreaks.

Data published by UKHSA shows that in Blackpool for 2024/25 (figure 1):

• • The number of children who had received the Haemophilus influenza type b and meningitis C (Hib/MenC) booster by age five was 1,703 (93.5%)
  • The number of children who received the combined Diptheira, Tetanus, Polio, Pertussis, Hib and HepB primary vaccine by age five was 1,724 (94.7%)
  • The number of children who received the combined Diptheira, Tetanus, Polio and Pertussis booster vaccine by age five was 1,559 (85.6%)
  • The number of children who had received the measles, mumps and rubella (MMR) vaccine, 1 dose, by age 5 years was 1,732 (95.1%)
  • The number of children who had received the measles, mumps and rubella (MMR) vaccine, 2 doses at age 5 years was 1,592 (87.4%)

Figure 1: percent of children immunised by their fifth birthday: 2024/25

Across Blackpool, immunisation uptake by the age of five years is higher than the national average. After a recent small dip trends for MMR (one and two doses), and DTaP/IPV booster show uptake is increasing locally, but still falling nationally. Two doses of MMR vaccine are required to provide satisfactory protection against measles, mumps and rubella, and although coverage in Blackpool is above the national average (figure 2) it remains below the goal of 90%. In 2024/25, 87.4% of Blackpool's children had two doses of the MMR vaccine by the time they began school. Approximately 5%-10% of children are not fully immune after only one dose of the vaccine, therefore the second dose provides a further opportunity to protect children, with less than 1% of children remaining susceptible after receiving the two recommended doses.²

Figure 2: trend in proportion of children immunised by their fifth birthday

Figure 3 shows the longer-term trend in the proportion of children who have received two doses of the MMR vaccine by their fifth birthday. In Blackpool coverage has increased from lower than the national average before 2019/20 to higher than average, though in recent years coverage had been falling nationally, regionally and locally. While the rates for Blackpool and the North West have increased from 2023/24, they still remains below the recommended target of 95% population coverage.  

Figure 3: trend in the proportion of children who have two doses of MMR vaccine by their fifth birthday

Figure 4 compares Blackpool with other local authorities in England. Blackpool ranks 69th out of 148 authorities with reported statistics and is in the third (middle) quintile for coverage.

Figure 4: proportion of children who have two doses of MMR vaccine by their fifth birthday, comparison showing Blackpool with upper tier local authorities in England, 2024/25 

National data reported that there were 157 laboratory-confirmed cases of mumps in England in 2024, compared to 23 cases in 2021 and 959 laboratory-confirmed cases of measles in 2025. In 2024 this was 2,911, the highest number of cases recorded annually since 2012.  Outside of London, the risk of measles is low but smaller outbreaks could be seen in specific populations, including teenagers, young people and under-vaccinated communities and it highlights the importance of ensuring that children are up-to-date with the MMR vaccination.³ Following the increases in measles, the UK Health Security Agency (UKHSA) launched a campaign in March 2024 to remind parents of the risks of their children missing out on protection against serious disease.

Human papillomavirus (HPV)

The HPV vaccine protects against two types of HPV virus (HPV-16 and HPV-18) which together are responsible for about 70% of cervical cancers. In addition, the vaccine can also protect against HPV-6 and HPV-11, the two strains of HPV that cause most cases of genital warts.

Since 2008, all 12 to 13 year old females (school year 8) in the UK have been offered the human papilloma virus (HPV) vaccination through the national HPV immunisation programme. From the 2019/20 school year, HPV vaccination was also extended to males aged 12 to 13. Following updated guidance in 2023, the NHS have now updated its HPV vaccination programme to a single dose instead of two doses for most under 25s, making it easier than ever for young people and parents of 12-13 year olds to ensure they are protected.

In 2023, the NHS also pledged to eliminate cervical cancer by 2040 for the first time ever, which could save thousands of lives every year in England, but this relies on as many young people as possible getting the lifesaving HPV vaccination and increasing cervical screening uptake.⁴

Due to the COVID-19 pandemic, all educational settings were closed from the 23 March 2020 and the delivery of the 2019/20 school immunisation programmes was paused, in line with UK Government COVID-19 guidance. This has had a significant impact on the uptake of the HPV vaccination programme. Latest figures overall indicate that uptake is reducing for both males and females for both one and two doses.  HPV vaccine uptake among school pupils is still well below pre-pandemic levels of around 90%.⁵

In Blackpool:

• • 66.6% (500) girls aged 12 to 13 years received their first dose vaccination for HPV compared to 81.8% in 2019/20 (pre pandemic) (2023/24)
  • 69.6% (489) of girls aged 13 to 14 years received their second dose vaccination for HPV compared to 83.8% in 2019/20 (2022/23)
  • 64.7% (488) of boys aged 12 to 13 years received their HPV vaccination compared to 77.6% in 2019/20

In COVID-affected 2020/21:

• • 72.4% (501) of girls aged 12 to 13 years received their first dose vaccination for HPV
  • 80.1% (520) of girls aged 13 to 14 years received their second dose
  • 64.7% (467) of males aged 12 to 13 years received their first dose vaccination for HPV
  • 79.2% (581) of males aged 13 to 14 years received their second dose 

Currently, coverage for males and females (one dose) is significantly lower than national and regional averages (figure 5) and is below the 80% uptake target. For second dosage although the proportions for Blackpool are above the national and regional values (for males and females), they are still significantly worse. 

Figure 5: proportion of children aged 12-13 (2023/24) receiving one dose and 13-14 receiving two doses (2022/23)

The trend for females for one and two doses is decreasing and getting worse. For males (one dose) the trend is also decreasing and getting worse. There are not enough data points to provide a trend for males (two doses).

Figure 6 : trend in proportion of females and males aged 12-13 (one dose) and 13-14 (two doses) receiving the HPV vaccine

Variation within Blackpool

At a local level, there is variation in the proportion of children immunised in each of Blackpool's GP practices, with several practices having rates significantly lower than the Blackpool average. Figure 8 shows immunisations by the age of 5 years and the proportion of children immunised by each practice in 2023/24.

Figure 8: Child Immunisations by the age of 5 years by GP Practice in Blackpool, 2023/24

'Our Children': looked-after children

In recent years there has been a renewed focus on improving outcomes for looked-after children and young people who can be at a higher risk of missing out on childhood vaccinations. Looked after children in Blackpool are significantly more likely to be up to date with their immunisations: in 2023, 93% of children in care for at least 12 months had all their immunisations compared to 82% nationally.

Risks

Reasons for low uptake of vaccinations may include poor access to healthcare services; inaccurate claims about safety and effectiveness, which can lead to increased concerns and a reduction in the perceived need for vaccines; and insufficient capacity in the healthcare system to provide vaccinations. In addition, problems with the recording of vaccination status and poor identification of people who are eligible to be vaccinated may have contributed to low uptake.⁶ 

Blackpool recognises that there is a need to target both overall improvement of immunisation coverage and specifically to improve the low levels of coverage amongst certain groups and in certain places.

Evidence has shown that the following groups of children and young people are at risk of not being fully immunised.⁶

• • People from some minority ethnic family backgrounds
  • People from Gypsy, Roma and Traveller communities
  • People with physical or learning disabilities
  • People from some religious communities (for example, Orthodox Jewish)
  • New migrants and asylum seekers
  • Looked-after children and young people
  • Children of young or lone parents
  • Children from large families
  • People who live in an area of high deprivation
  • Babies or children who are hospitalised or have a chronic illness, and their siblings
  • People not registered with a GP
  • People from non-English-speaking families
  • People who are homeless 

Vaccine hesitancy

In recent years, vaccine hesitancy has been on the rise with more people questioning vaccination as anti-vaccine messages have been amplified on social media. As a result, vaccine hesitancy is slowly chipping away at the eradication achieved for various infectious diseases, including polio and measles. 

In 2023 around 70% of UK adults said that vaccinations were safe and effective, down sharply from 90% in 2018, according to research from the Vaccine Confidence Project, run by the London School of Hygiene and Tropical Medicine (LSHTM). At the same time, childhood vaccination rates have fallen further below recommended levels over the last five years, continuing a longer-term trend.⁷

Mitigating vaccine hesitancy is crucial for public health, and there are several strategies that can help:

• • Improving Public Trust in Vaccines
  • Fostering Education and Awareness
  • Engaging with Communities
  • Improving Access and Convenience
  • Addressing Specific Concerns

It’s important to take a holistic approach that involves communication, education, accessibility, and empathy so that vaccine hesitancy can be addressed more effectively. 

National and local strategies

Department of Health (2024) immunisation information for health professionals and immunisation practitioners

The 'Green Book' has the latest information on vaccines and vaccination procedures, for vaccine-preventable infectious diseases in the UK.

The Complete Immunisation Schedule in the UK includes the ages of when the vaccines should be given.

NICE guideline [NG218] Vaccine uptake in the general population, May 2022 aims to increase the uptake of all vaccines by everyone who is eligible. It supports the aims of the NHS Long Term Plan, which includes actions to improve immunisation coverage by GPs and support a narrowing of health inequalities.

NHS England’s NHS vaccination strategy (January 2024) is for people and organisations involved in the commissioning, planning and delivery of NHS vaccination services in England and will aim to not only increase overall uptake and coverage of vaccinations, but to reduce disparity in uptake.

[1] WHO Regional Office for Europe, European Immunization Agenda 2030, 2021

[2] UKHSA, The Green Book of Immunisation, Chapter 21, December 2019

[3] UKHSA, Laboratory confirmed cases of measles, rubella and mumps in England, 2025

[4] NHS England, NHS sets ambition to eliminate cervical cancer by 2040, November 2023

[5] UKHSA, Young people urged to catch-up on missed HPV vaccines, January 2025

[6] NICE guideline [NG218] Vaccine uptake in the general population, May 2022

[7] BBC Indepth, Rise of vaccine distrust - why more of us are questioning jabs, January 2025 [Accessed 26/02/2025]